Antacid Use in Infancy Linked to Higher Risk of Celiac Disease

Researchers reported an increased risk of death among PPI users.

morrowlight/Shutterstock

Using acid-suppressing medications to treat gastroesophageal reflux disease (GERD) in infants increases the risk of developing celiac disease by 50 percent, according to new research.

GERD is a common condition in the United States, with roughly 25 percent of infants experiencing gastroesophageal reflux symptoms at some point.

Potential Link but No Clear Correlation

A large study of nearly 80,000 children found that those given common infant reflux drugs were slightly more likely to show early signs of celiac disease compared with those who weren’t.